1. Home
  2. AUID vs XLO Comparison

AUID vs XLO Comparison

Compare AUID & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.24

Market Cap

35.6M

Sector

Technology

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.72

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
XLO
Founded
2009
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
41.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AUID
XLO
Price
$1.24
$0.72
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
3.6M
648.7K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,834,458.00
$31,804,000.00
Revenue This Year
N/A
$589.60
Revenue Next Year
N/A
$38.00
P/E Ratio
N/A
N/A
Revenue Growth
141.81
588.40
52 Week Low
$1.15
$0.62
52 Week High
$9.58
$1.70

Technical Indicators

Market Signals
Indicator
AUID
XLO
Relative Strength Index (RSI) 34.69 43.26
Support Level $1.15 $0.69
Resistance Level $1.38 $0.75
Average True Range (ATR) 0.23 0.04
MACD 0.00 -0.00
Stochastic Oscillator 7.89 30.90

Price Performance

Historical Comparison
AUID
XLO

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: